EPISODE · Dec 19, 2025 · 1H 3M
Triple Negative Breast cancer Survivor Felicia Mahone shares battle then and now 18 years later
from Power Over Pink Breast Cancer Survivor stories and health tips · host Power Over Pink
The conversation covers the personal journey of Felicia Mahone, including the impact of genetic factors on breast cancer, navigating the healthcare system without insurance, the emotional impact and coping strategies, advocacy and patient support, treatment experience and complications, the impact of treatment on daily life, insurance and healthcare provider experience, and challenges and decisions regarding ovarian cancer risk. The conversation covers the challenges of fertility and reproductive health, the impact of cancer on quality of life, and the importance of advocating for oneself. It also delves into the financial burden of fertility treatments, the emotional toll of cancer treatment, and the need for support and advocacy. Additionally, it explores the cultural and historical influences on women's roles, the sacrifices of women in the face of illness, and the impact of illness on employment and financial stability. The conversation emphasizes the importance of choosing oneself, the lack of financial guidance for cancer patients, and the power of faith and hope. It also highlights the importance of seeking help and support, empowering young girls and women, and turning trauma into advocacy and support through a nonprofit organization.TakeawaysGenetic factors in breast cancerNavigating the healthcare system without insurance Importance of advocating for oneselfChallenges of fertility and reproductive healthThe impact of cancer on quality of lifeChapters00:00 Challenges and Decisions Regarding Ovarian Cancer Risk01:12:02 The Nonprofit and Its Mission
Embed this episode
Ready to play
Triple Negative Breast cancer Survivor Felicia Mahone shares battle then and now 18 years later
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.